Case Studies
Regardless which phase of the product’s lifecycle a company is dealing with – the early clinical stage or even some time after licensing – our collection of publications will demonstrate which challenges a company can be confronted with during the entire process.
Based on our analysis and consultation, a start up sets up new structures and processes allowing them to produce an operate more efficiently along the way to market.
We advised the company’s development team in outlining a regulatory strategy that was discussed with the multidisciplinary expert team at the European Medicines Agency (EMA) / Innovative Task Force (ITF).
powered by Borlabs Cookie